During the past decade, MeCRU Clinical Research Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MeCRU Clinical Research Unit" are "HIV-1" (1 trials) and "Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol" (1 trials). Many other conditions were trialed in "MeCRU Clinical Research Unit" in a lesser frequency.

Most popular intervention types in "MeCRU Clinical Research Unit" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ad26.COV2.S" (1 trials), "Ad26.Mos4.HIV" (1 trials) and "Clade C gp140" (1 trials). Other intervention names were less common.

The vast majority of trials in "MeCRU Clinical Research Unit" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "MeCRU Clinical Research Unit". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in MeCRU Clinical Research Unit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MeCRU Clinical Research Unit, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".